The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis

The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis

Background: The evidence of using JAK inhibitors among hospitalized patients with COVID-19 is conflicting. The systematic review and meta-analysis aimed to address the efficacy of Janus Kinase (JAK) Inhibitors in reducing risk of mortality among hospitalized patients with COVID-19. Methods: Several...

Full description

Bibliographic Details
Main Authors: Indra Wijaya, Rizky Andhika, Ian Huang, Aga Purwiga, Kevin Yonatan Budiman, Muhammad Hasan Bashari, Lelani Reniarti, Rully Marsis Amirullah Roesli
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Clinical Epidemiology and Global Health
Subjects:
Janus kinase inhibitors
COVID-19
SARS-CoV-2
Mortality
Clinical outcome
Online Access:http://www.sciencedirect.com/science/article/pii/S2213398421000592

Internet

http://www.sciencedirect.com/science/article/pii/S2213398421000592

Similar Items